Lowering PCSK9 and LDL-C therefore appears beneficial in the context of ischemic stroke but further investigations are needed to test whether PCSK9 inhibition impacts hemorrhagic stroke. This evidence concerns the gene PCSK9 and hemorrhagic stroke.